Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: EyeDrMike who wrote (10044)	6/25/1998 12:47:00 PM
From: Neil_L	Read Replies (2) \| Respond to of 23519

Some cold water from briefing.com. 09:32 ET VIVUS Inc (VVUS) 6 1/4 +1/4: FDA has cleared the company's supplemental application for commercial production of its erectile dysfunction treatment MUSE in its new 90,000 square foot plant located in Lakewood, New Jersey. Before Viagra, VVUS couldn't keep up with demand. Now company having no problem. The ability to increase production for a product that is losing market share is hard to be perceived as positive, unless you are a die-hard VVUS investor (or user). Guess I'm a die-hard... Neil.